These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12584467)

  • 1. Treatment of hypertension in renal transplant recipients.
    Tylicki L; Habicht A; Watschinger B; Hörl WH
    Curr Opin Urol; 2003 Mar; 13(2):91-8. PubMed ID: 12584467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypertension following kidney transplantation.
    Rubin MF
    Adv Chronic Kidney Dis; 2011 Jan; 18(1):17-22. PubMed ID: 21224026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypertension in kidney transplant recipients.
    Ponticelli C; Cucchiari D; Graziani G
    Transpl Int; 2011 Jun; 24(6):523-33. PubMed ID: 21382101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension, antihypertensive agents and outcomes following renal transplantation.
    Tutone VK; Mark PB; Stewart GA; Tan CC; Rodger RS; Geddes CC; Jardine AG
    Clin Transplant; 2005 Apr; 19(2):181-92. PubMed ID: 15740553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium channel blockers as the treatment of choice for hypertension in renal transplant recipients: fact or fiction.
    Baroletti SA; Gabardi S; Magee CC; Milford EL
    Pharmacotherapy; 2003 Jun; 23(6):788-801. PubMed ID: 12820820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Arterial hypertension in renal transplant recipients].
    Basić-Jukić N; Jurić I; Kes P; Bubić-Filipi L; Brunetta B; Pasini J
    Acta Med Croatica; 2007 Apr; 61(2):171-6. PubMed ID: 17585473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension guidelines: How do they apply to kidney transplant recipients.
    Aziz F; Clark D; Garg N; Mandelbrot D; Djamali A
    Transplant Rev (Orlando); 2018 Oct; 32(4):225-233. PubMed ID: 30293557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Severe renovascular hypertension in a recipient of renal transplant: an indication for nephrectomy?
    Barril G; Gonzalez C; Resano M; Perez R; Valderrabano F
    Nephron; 1983; 34(1):67-70. PubMed ID: 6343903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypertension after renal transplantation.
    Schwenger V; Zeier M; Ritz E
    Curr Hypertens Rep; 2001 Oct; 3(5):434-9. PubMed ID: 11551380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inadequate blood pressure control in most kidney transplant recipients and patients with coronary artery disease with and without complications.
    Małyszko J; Małyszko J; Bachórzewska-Gajewska H; Poniatowski B; Dobrzycki S; Mysliwiec M
    Transplant Proc; 2009 Oct; 41(8):3069-72. PubMed ID: 19857679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The best way to manage hypertension after renal transplantation.
    Kew CE; Curtis JJ
    J Ren Nutr; 2000 Jan; 10(1):3-6. PubMed ID: 10671627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Secondary hypertension].
    Kawabe H; Saito I
    Nihon Rinsho; 2001 May; 59(5):938-44. PubMed ID: 11391995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Renin-Angiotensin System Blockage and Avoiding High Doses of Calcineurin Inhibitors Prevent Interstitial Fibrosis and Tubular Atrophy in Kidney Transplant Recipients.
    Sayin B; Canver B; Gurlek Demirci B; Colak T; Ozdemir BH; Haberal M
    Exp Clin Transplant; 2017 Feb; 15(Suppl 1):32-36. PubMed ID: 28260428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypertension, living kidney donors, and transplantation: where are we today?
    Rossi AP; Vella JP
    Adv Chronic Kidney Dis; 2015 Mar; 22(2):154-64. PubMed ID: 25704353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Immunosuppressive Medications in the Pathogenesis of Hypertension and Efficacy and Safety of Antihypertensive Agents in Kidney Transplant Recipients.
    Divac N; Naumović R; Stojanović R; Prostran M
    Curr Med Chem; 2016; 23(19):1941-52. PubMed ID: 26687832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal hemodynamics in hypertensive renal allograft recipients: effects of calcium antagonists and ACE inhibitors.
    Grekas D; Dioudis C; Kalevrosoglou I; Alivanis P; Derveniotis V; Tourkantonis A
    Kidney Int Suppl; 1996 Jun; 55():S97-100. PubMed ID: 8743523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of Hypertension in Renal Transplant Recipients in Four Independent Cross-Sectional Analyses.
    Kuźmiuk-Glembin I; Adrych D; Tylicki L; Heleniak Z; Garnier H; Wiśniewski J; Rutkowski P; Rutkowski B; Dębska-Ślizień A
    Kidney Blood Press Res; 2018; 43(1):45-54. PubMed ID: 29402869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug therapy of renovascular hypertension.
    Rosenthal T
    Drugs; 1993 Jun; 45(6):895-909. PubMed ID: 7691497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prediction of chronic renal allograft dysfunction from evaluations of TGFBeta1 and the renin-angiotensin system.
    Yamada K; Hatakeyama E; Arita S; Sakamoto K; Kashiwabara H; Hamaguchi K
    Clin Exp Nephrol; 2003 Sep; 7(3):238-42. PubMed ID: 14586721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Stenosis of the renal artery of the transplant: comparison between interventional and medical treatment].
    Bernadet P; Durand D; Joffre F; Rostaing L; Rischman F; Sarramon JP; Tack I
    Arch Mal Coeur Vaiss; 1994 Aug; 87(8):1107-10. PubMed ID: 7755469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.